These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8462218)

  • 41. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
    Afshan A; Sohaib M; Jehangir M
    Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation exposure by technitium-99m MAG3.
    Bubeck B
    J Nucl Med; 1989 May; 30(5):720-1. PubMed ID: 2523960
    [No Abstract]   [Full Text] [Related]  

  • 43. [Preparation and primary application of a new renal function imaging 99mTc-MAG3].
    Deng HF; Tan TZ; Liang ZG; Xu Z; Liu ZL
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):279-81. PubMed ID: 2978155
    [No Abstract]   [Full Text] [Related]  

  • 44. 99mTc-MAG3 renogram deconvolution analysis as a diagnostic aid in kidney graft monitoring.
    Bajén MT; Martin-Comin J; Gonzalez A; Castelao AM; Griño JM; Roca M; Mora J; Puchal R
    Transplant Proc; 1995 Aug; 27(4):2221. PubMed ID: 7652780
    [No Abstract]   [Full Text] [Related]  

  • 45. Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).
    Zuckier LS
    Urology; 2011 Apr; 77(4):1011; author reply 1011-2. PubMed ID: 21477735
    [No Abstract]   [Full Text] [Related]  

  • 46. The detection of vesicoureteral reflux in the nonfunctioning lower half of an òccult' duplex kidney by Tc-99m MAG3 indirect radionuclide cystography.
    De Palma D; Manzoni GA
    Clin Nucl Med; 2000 Aug; 25(8):628-9. PubMed ID: 10944023
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Follow-up after kidney transplantation. Sequential functional scintigraphy with technetium-99m-DTPA or technetium-99m-MAG3].
    Kramer W; Baum RP; Scheuermann E; Hör G; Jonas D
    Urologe A; 1993 Mar; 32(2):115-20. PubMed ID: 8475609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there still a need for Tc-99m DMSA renal imaging?
    Bair HJ; Becker W; Schott G; Kühn RH; Wolf F
    Clin Nucl Med; 1995 Jan; 20(1):18-21. PubMed ID: 7895429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The differential use of 99mTc-DTPA and 99mTc-MAG3 in the aftercare of kidney transplant patients].
    Kotzerke J; Burchert W; Ringe B; Hundeshagen H
    Rofo; 1990 Feb; 152(2):241-2. PubMed ID: 2155467
    [No Abstract]   [Full Text] [Related]  

  • 52. [Photon-deficient kidney in 99mTc-DTPA serial scintigraphy (author's transl)].
    Seto H; Kakishita M; Futatsuya R; Ichiyanagi K; Hisada K
    Kaku Igaku; 1981 Nov; 18(9):1255-61. PubMed ID: 7040748
    [No Abstract]   [Full Text] [Related]  

  • 53. [99m-Technetium-mercaptoacetyltriglycine (MAG3) for the demonstration of the kidney changes following extracorporeal shockwave lithotripsy. A prospective study of 117 patients].
    Schaub T; Witsch U; el-Damanhoury H; Nägele-Wöhrle B; Hahn K
    Rofo; 1992 Oct; 157(4):338-43. PubMed ID: 1391835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAG3 renal transplant tomography SPECT with a non-SPECT agent.
    Neubauer N; Johnson L; Lemmers M; Petri B; Stevens JS
    Clin Nucl Med; 1996 Jan; 21(1):11-4. PubMed ID: 8741882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gallbladder simulating renal fracture during technetium-99m glucoheptonate evaluation for renal trauma.
    Alexieva-Jackson B; Fetters DV; Cole RL; Upton JD; Jackson JH; Holder JR; Strawn RE
    Clin Nucl Med; 1986 May; 11(5):363-4. PubMed ID: 3698438
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of renal function by factor analysis using 99mTc-MAG3].
    Hosokawa C; Ushijima Y; Okamura T; Kawabe J; Hata M; Oda J; Ochi H
    Kaku Igaku; 1994 May; 31(5):501-5. PubMed ID: 8028222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetry of
    Arteaga MV; Caballero VM; Rengifo KM
    Appl Radiat Isot; 2018 Aug; 138():25-28. PubMed ID: 28781122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Tc-99m MAG3 dynamic renal scintigraphy with an aneurysmal type renal arteriovenous fistula.
    Horita Y; Nakamura S; Hirashima S; Tadokoro M; Taura K; Suyama N; Sakamoto I; Nishikido M; Miyazaki M; Kohno S
    Clin Nucl Med; 2003 May; 28(5):429-31. PubMed ID: 12702950
    [No Abstract]   [Full Text] [Related]  

  • 60. Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine.
    Gates GF
    Clin Nucl Med; 2004 Apr; 29(4):231-7. PubMed ID: 15096969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.